WEBSITE BSE:506854 NSE : TANFAC IND. 10 May, 16:01
Market Cap ₹2206 Cr.
Stock P/E 39.0
P/B 9.6
Current Price ₹2212
Book Value ₹ 231
Face Value 10
52W High ₹2778.7
Dividend Yield 0.32%
52W Low ₹ 1590
TANFAC Industries Ltd gives Aluminium Fluoride, AHF Acid and Sulphuric Acid, and Speciality Chemicals. The Company operates via Fluro-Chemicals in India phase. Its product variety consists of Boron Trifluoride Complexes, Diluted Hydrofluoric Acid, Iso Butyl Acetophenone, Acetic Acid, Peracetic Acid, Oleum, Gymsum (Anhydride), Potassium Bifluoride, Potassium Fluoride and Sodium Silico Fluoride. Its aluminium fluoride is used as a makeup component within the molten electrolyte of the aluminium reduction cell and in electrolytic procedure for refining aluminium, and sulfuric acid has programs, which includes manufacture of fertilizers, treatment of metals and purification of petroleum. Its anhydrous hydrofluoric acid is used as a catalyst in petrochemical industry for alkylation, and inside the manufacture of refrigerants, and organic and inorganic fluorine compounds. Its manufacturing facilities are over 60 acres in the chemical complex of SIPCOT Industrial Estate, Cuddalore.
Price goes above X
Price falls below X
PE goes above X
PE falls below X
₹ | |
#(Fig in Cr.) | Sep 2021 | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 73 | 90 | 67 | 83 | 77 | 99 | 116 | 81 | 88 | 103 |
Other Income | 0 | 1 | 1 | 0 | 0 | 1 | 6 | 2 | 1 | 2 |
Total Income | 73 | 91 | 68 | 83 | 78 | 100 | 122 | 83 | 89 | 105 |
Total Expenditure | 58 | 69 | 57 | 70 | 65 | 76 | 90 | 66 | 73 | 86 |
Operating Profit | 15 | 22 | 11 | 14 | 13 | 23 | 32 | 17 | 16 | 18 |
Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Depreciation | 2 | 1 | 1 | 1 | 2 | 2 | 2 | 2 | 2 | 2 |
Exceptional Income / Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | 14 | 20 | 9 | 12 | 12 | 22 | 30 | 15 | 14 | 16 |
Provision for Tax | 4 | 6 | 2 | 3 | 3 | 5 | 8 | 4 | 4 | 4 |
Profit After Tax | 10 | 15 | 7 | 9 | 9 | 16 | 22 | 11 | 10 | 13 |
Adjustments | 0 | -0 | -0 | 0 | 0 | 0 | -0 | -0 | -0 | 0 |
Profit After Adjustments | 10 | 15 | 7 | 9 | 9 | 16 | 22 | 11 | 10 | 13 |
Adjusted Earnings Per Share | 10 | 15 | 7.1 | 9 | 8.5 | 16.3 | 22.4 | 11.4 | 10.1 | 12.7 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | TTM |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Net Sales | 146 | 117 | 120 | 133 | 126 | 162 | 222 | 165 | 148 | 320 | 375 | 388 |
Other Income | 2 | 0 | 0 | 0 | 1 | 0 | 1 | 1 | 1 | 3 | 8 | 11 |
Total Income | 147 | 118 | 120 | 134 | 127 | 162 | 223 | 166 | 149 | 324 | 383 | 399 |
Total Expenditure | 147 | 106 | 112 | 125 | 112 | 141 | 169 | 138 | 115 | 244 | 299 | 315 |
Operating Profit | 1 | 12 | 8 | 9 | 15 | 21 | 53 | 28 | 35 | 80 | 84 | 83 |
Interest | 12 | 10 | 10 | 8 | 7 | 7 | 4 | 2 | 1 | 2 | 2 | 0 |
Depreciation | 10 | 7 | 6 | 5 | 5 | 5 | 8 | 5 | 8 | 6 | 6 | 8 |
Exceptional Income / Expenses | 6 | 0 | 0 | 4 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Profit Before Tax | -15 | -6 | -7 | 0 | 3 | 10 | 42 | 22 | 25 | 72 | 75 | 75 |
Provision for Tax | -4 | -2 | -1 | -0 | 0 | 0 | 6 | 5 | 8 | 19 | 19 | 20 |
Profit After Tax | -11 | -3 | -5 | 0 | 3 | 10 | 36 | 17 | 17 | 53 | 56 | 56 |
Adjustments | 0 | 0 | 0 | 0 | -0 | -0 | 0 | 0 | 1 | 1 | -0 | 0 |
Profit After Adjustments | -11 | -3 | -5 | 0 | 3 | 9 | 36 | 17 | 18 | 54 | 56 | 56 |
Adjusted Earnings Per Share | -11.4 | -3 | -5.3 | 0.4 | 3.3 | 9.7 | 36.1 | 17 | 17.5 | 53.4 | 56.3 | 56.6 |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Sales CAGR | 17% | 31% | 18% | 10% |
Operating Profit CAGR | 5% | 44% | 32% | 56% |
PAT CAGR | 6% | 49% | 41% | 0% |
# | 1 Year | 3 Year | 5 Year | 10 Year |
---|---|---|---|---|
Share Price CAGR | 36% | 113% | 59% | 74% |
ROE Average | 35% | 36% | 51% | 22% |
ROCE Average | 49% | 51% | 54% | 30% |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Shareholder's Funds | 8 | 5 | 5 | 5 | 3 | 13 | 48 | 65 | 83 | 134 | 184 |
Minority's Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Borrowings | 5 | 2 | 0 | 0 | 6 | 7 | 6 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 5 | 2 | 1 | 1 | 1 | 1 | 6 | 5 | 4 | 4 | 4 |
Total Current Liabilities | 90 | 98 | 90 | 86 | 68 | 68 | 48 | 19 | 44 | 56 | 82 |
Total Liabilities | 108 | 107 | 95 | 92 | 78 | 88 | 107 | 89 | 131 | 193 | 271 |
Fixed Assets | 65 | 59 | 53 | 49 | 45 | 41 | 34 | 33 | 40 | 40 | 55 |
Other Non-Current Assets | 1 | 1 | 1 | 2 | 3 | 2 | 3 | 8 | 5 | 14 | 8 |
Total Current Assets | 42 | 46 | 41 | 41 | 30 | 45 | 70 | 48 | 86 | 139 | 208 |
Total Assets | 108 | 107 | 95 | 92 | 78 | 88 | 107 | 89 | 131 | 193 | 271 |
#(Fig in Cr.) | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Opening Cash & Cash Equivalents | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 7 |
Cash Flow from Operating Activities | 26 | 19 | 9 | 16 | 16 | 17 | 37 | 22 | 37 | 44 | 43 |
Cash Flow from Investing Activities | -0 | -0 | -0 | -1 | -1 | -1 | -3 | -9 | -34 | -35 | -40 |
Cash Flow from Financing Activities | -26 | -19 | -10 | -15 | -15 | -17 | -34 | -12 | -1 | -5 | -6 |
Net Cash Inflow / Outflow | -0 | -0 | -0 | -0 | 0 | -0 | 0 | -0 | 2 | 5 | -3 |
Closing Cash & Cash Equivalent | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 7 | 4 |
# | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 |
---|---|---|---|---|---|---|---|---|---|---|---|
Earnings Per Share (Rs) | -11.38 | -3.04 | -5.3 | 0.4 | 3.3 | 9.7 | 36.06 | 17.02 | 17.52 | 53.42 | 56.27 |
CEPS(Rs) | -0.88 | 3.9 | 0.34 | 5.18 | 8.05 | 14.65 | 44.1 | 21.67 | 26.01 | 59.03 | 62.62 |
DPS(Rs) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 9 | 6.5 |
Book NAV/Share(Rs) | 8.48 | 5.44 | -0.35 | 0.06 | 3.26 | 12.67 | 48.15 | 65.36 | 83.44 | 134.03 | 184.74 |
Core EBITDA Margin(%) | -0.75 | 8.63 | 6.03 | 5.96 | 10.44 | 12.69 | 23.7 | 16.26 | 22.5 | 23.79 | 20.3 |
EBIT Margin(%) | -2.13 | 3.57 | 2.34 | 5.5 | 7.57 | 9.91 | 20.51 | 14.16 | 17.69 | 23.1 | 20.73 |
Pre Tax Margin(%) | -9.51 | -4.26 | -5.01 | 0.26 | 2.37 | 5.92 | 18.78 | 13.12 | 16.94 | 22.47 | 20.13 |
PAT Margin (%) | -7.01 | -2.34 | -4.01 | 0.27 | 2.37 | 5.85 | 16.22 | 10.3 | 11.82 | 16.64 | 14.97 |
Cash Profit Margin (%) | -0.54 | 3 | 0.26 | 3.52 | 5.79 | 8.84 | 19.84 | 13.11 | 17.55 | 18.39 | 16.66 |
ROA(%) | -8.4 | -2.83 | -5.24 | 0.43 | 3.88 | 11.65 | 36.76 | 17.27 | 15.86 | 32.85 | 24.19 |
ROE(%) | -83.52 | -43.71 | -208.26 | 0 | 198.92 | 121.81 | 118.59 | 29.98 | 23.54 | 49.13 | 35.31 |
ROCE(%) | -3.46 | 5.7 | 4.29 | 12.42 | 17.76 | 28.95 | 78.46 | 37.2 | 35.16 | 68.2 | 48.88 |
Receivable days | 41.75 | 47.09 | 48.53 | 45.84 | 47.17 | 39.01 | 34.85 | 45.26 | 41.9 | 23.33 | 36.84 |
Inventory Days | 61.69 | 61.08 | 63.33 | 48.55 | 37.82 | 30.62 | 38.85 | 52.35 | 51.45 | 37.81 | 46.03 |
Payable days | 49.4 | 90.45 | 101.29 | 93.99 | 98.97 | 62.41 | 74.23 | 80.01 | 100.14 | 66.75 | 68.02 |
PER(x) | 0 | 0 | 0 | 62.52 | 18.63 | 11.7 | 6.03 | 4.65 | 13.95 | 10.89 | 17.73 |
Price/Book(x) | 1.58 | 1.52 | -42.43 | 451.21 | 18.85 | 8.96 | 4.52 | 1.21 | 2.93 | 4.34 | 5.4 |
Dividend Yield(%) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1.55 | 0.65 |
EV/Net Sales(x) | 0.63 | 0.66 | 0.7 | 0.64 | 0.91 | 0.97 | 1.03 | 0.48 | 1.6 | 1.77 | 2.62 |
EV/Core EBITDA(x) | 174.33 | 6.66 | 10.14 | 9.44 | 7.54 | 7.34 | 4.26 | 2.84 | 6.85 | 7.13 | 11.69 |
Net Sales Growth(%) | -1.38 | -19.57 | 2.33 | 11.18 | -5.2 | 28.08 | 36.96 | -25.67 | -10.26 | 116.49 | 17.11 |
EBIT Growth(%) | 69.99 | 234.06 | -33.34 | 161.51 | 30.1 | 56.14 | 177.4 | -48.69 | 12.15 | 182.71 | 5.07 |
PAT Growth(%) | 52.91 | 73.26 | -74.32 | 107.59 | 720.56 | 193.9 | 271.65 | -52.81 | 2.94 | 204.93 | 5.34 |
EPS Growth(%) | 52.91 | 73.26 | -74.32 | 107.59 | 720.57 | 193.9 | 271.65 | -52.81 | 2.94 | 204.93 | 5.34 |
Debt/Equity(x) | 9.32 | 12.83 | 13.81 | 11.08 | 16.56 | 3.44 | 0.25 | 0.01 | 0 | 0 | 0 |
Current Ratio(x) | 0.47 | 0.48 | 0.46 | 0.48 | 0.45 | 0.66 | 1.47 | 2.58 | 1.97 | 2.49 | 2.53 |
Quick Ratio(x) | 0.26 | 0.22 | 0.22 | 0.27 | 0.29 | 0.41 | 0.83 | 1.66 | 1.41 | 1.74 | 1.88 |
Interest Cover(x) | -0.29 | 0.46 | 0.32 | 1.05 | 1.46 | 2.49 | 11.85 | 13.67 | 23.69 | 36.56 | 34.45 |
Total Debt/Mcap(x) | 5.91 | 8.45 | 4.38 | 2.23 | 0.88 | 0.38 | 0.05 | 0.01 | 0 | 0 | 0 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 50.98 | 50.98 | 51.81 | 51.81 | 51.81 | 51.81 | 51.81 | 51.81 | 51.81 | 51.81 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.06 | 0.11 |
Public | 48.96 | 48.96 | 48.13 | 48.13 | 48.13 | 48.13 | 48.13 | 48.13 | 48.13 | 48.08 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 | 100 |
# | Dec 2021 | Mar 2022 | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|---|---|---|---|---|
Promoter | 0.51 | 0.51 | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 | 0.52 |
FII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Public | 0.49 | 0.49 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 | 0.48 |
Others | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Pros
Cons
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Sell or Purchase Share (Tentative Price)
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
Companies | Open Date | Close Date | Issue Price | Cost of 1 Lot | GMP | Expected Listing | Listing Gain(%) | Listing Price | Current Price | Type | Exchange |
---|
You May Also Know About